🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Randomized, controlled, double-blind, single-center, double-blind clinical ...
Status
Completed
Location
Catholic University of Murcia
Start Date
2023-12-04
Trial ID
NCT06180512
Treatments Being Tested
This is a phase II, observer-blind, multiple-centre, randomized, placebo-co...
Status
Terminated
Location
Changhua Christian Hospital
Start Date
2021-01-30
Trial ID
NCT04773067
RATIONALE: Peripheral stem cell transplantation may be able to replace immu...
Status
Terminated
Location
Robert H. Lurie Comprehensive Cancer Center, Northwestern University
Start Date
1999-09
Trial ID
NCT00005787
In this i-SABR (immunotherapy + Stereotactic Ablative Body Radiation) trial...
Status
Completed
Location
University of Texas Southwestern Medical Center
Start Date
2013-10-02
Trial ID
NCT01896271
Treatments Being Tested
Neutropenia, a condition characterized by an abnormally low number of infec...
Status
Completed
Location
University of Iowa Hospitals and Clinics
Start Date
2008-04
Trial ID
NCT00627393
Treatments Being Tested
RATIONALE: Radioactive iodine uses radiation to kill tumor cells. Giving io...
Status
Unknown
Location
Sussex Cancer Centre at Royal Sussex County Hospital
Start Date
2006-11
Trial ID
NCT00415233
Treatments Being Tested
This study uses an unconventional radiotherapy schedule developed at our in...
Status
Terminated
Location
KABEG Klinikum Klagenfurt, Institute for Radiation Oncology
Start Date
2018-10-30
Trial ID
NCT04168320
Treatments Being Tested
This is an open-label, multicenter, Phase Ib study to determine the maximum...
Status
Completed
Location
Rigshospitalet
Start Date
2021-07-14
Trial ID
NCT04826003
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Herbert Irving Comprehensive Cancer Center
Start Date
1996-05
Trial ID
NCT00008203
The purpose of this study is to assess whether abciximab is associated with...
Status
Completed
Location
Allgemeines Krankenhaus Wien
Start Date
2003-06
Trial ID
NCT00133250
Treatments Being Tested